DRAD Digirad Corporation featured news, full reports, and detailed charts
Digirad Corporation (DRAD) Wrap Up:
We are a leading provider of cardiovascular imaging services and solid-state nuclear medicine imaging products to physician offices, hospitals and other medical services providers. We designed and commercialized the first solid-state nuclear gamma camera for the detection of cardiovascular disease and other medical conditions. Our imaging systems are mobile as well as fixed and provide enhanced operability, improved patient comfort and, in the case of our triple-headed Cardius®-3 XPO system, shorter image acquisition time when compared to traditional vacuum tube cameras. The cameras and accompanying equipment fit easily into floor spaces as small as seven feet by eight feet and facilitate the delivery of nuclear medicine procedures in a physician’s office, an outpatient hospital setting or within multiple departments of a hospital. For the year ended December 31, 2007, our wholly-owned subsidiaries, Digirad Imaging Solutions, Inc. and Digirad Ultrascan Solutions, Inc. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f13%2f0001193125-08-029462.html#FIS_BUSINESS"Digirad Corporation (DRAD:NASDAQ)
Snapshot of Digirad Corporation (DRAD)
|
OPEN
$2.22
|
PREVIOUS CLOSE
$2.25
|
|
|
DAY HIGH
$2.30
|
DAY LOW
$2.19
|
|
|
52 WEEK HIGH
09/30/09 - $3.14
|
52 WEEK LOW
12/8/08 - $0.48
|
|
|
MARKET CAP
42.1M
|
AVERAGE VOLUME 3 mo
140.1K
|
|
|
DILUTED EPS TTM
$-0.16
|
SHARES OUTSTANDING
19.0M
|
|
|
DRAD Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
DRAD Top Compensated Officers
Executives, Board Directors
Key developments for Digirad Corporation (DRAD)
Digirad Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported net loss of $414,000 or $0.02 per basic and diluted share on total revenue of $16,928,000 against net loss of $869,000 or $0.05 per basic and diluted share on total revenue of $20,203,000 for the same period a year ago. Loss from operations of $514,000 compared to $981,000 for the same period a year ago. Total revenue decreased mainly due to the sale of fewer nuclear gamma cameras that resulted from economy-driven tightening of hospital budgets and debt availability. For the nine months, the company reported net income of $414,000 or $0.02 per basic and diluted share on total revenue of $53,197,000 against net loss of $3,420,000 or $0.18 per basic and diluted share on total revenue of $58,371,000 for the same period a year ago. Income from operations of $29,000 compared to loss from operations of $4,095,000 for the same period a year ago. Total revenue decreased mainly due to the sale of certain Digirad Imaging Solutions hubs earlier this year and fewer nuclear gamma camera sales.
To discuss the company's business, strategic focus and outlook
Digirad Corporation announced the immediate availability of c.pax(TM), a combined structured reporting and picture archiving and communication system (PACS) in an online solution. Digirad's fully-integrated approach reduces capital costs; information technology (IT) support and maintenance costs; increases practice workflow efficiency; and extends access of CVIS, for the first time, to practices of all sizes.
DRAD Competitors
| Company | Last | Change | |
| No competitor information is available for DRAD. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | DRAD | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.6x |
|
| Price/Book | 0.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.2x |
|
|
DRAD |
||
DRAD transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
